J&J reported $197.42B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
AbbVie USD 147.68B 12.57B Sep/2026
Abbott USD 108.25B 968M Sep/2026
Amgen USD 96.05B 409M Sep/2026
AstraZeneca USD 119.92B 4.09B Sep/2026
Baxter International USD 19.41B 377M Sep/2026
Bayer EUR 113.47B 6.18B Sep/2026
Becton, Dickinson and Co. USD 50.79B 60M Sep/2026
Biogen USD 32.05B 32.5M Sep/2026
Boston Scientific USD 45.46B 245M Sep/2026
Bristol-Myers Squibb USD 88.77B 1.14B Sep/2026
CONMED USD 2.3B 4.16M Sep/2026
Cooper Companies USD 12.67B 191.1M Jun/2026
Dexcom USD 6.24B 216.5M Sep/2026
Edwards Lifesciences USD 14.14B 277.3M Sep/2026
Eli Lilly USD 148.07B 5.79B Sep/2026
Gilead Sciences USD 51.41B 2.05B Sep/2026
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
Globus Medical USD 5.53B 39.93M Sep/2026
Insulet USD 3.42B 250M Sep/2026
Integra LifeSciences USD 3.51B 55.69M Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Medtronic USD 93.31B 278M Jun/2026
Merck USD 132.77B 2.97B Sep/2026
Merit Medical Systems USD 2.92B 61.29M Sep/2026
Novartis USD 117.15B 4.88B Sep/2026
Pfizer USD 204.54B 3.41B Sep/2026
Regeneron Pharmaceuticals USD 44.41B 2.67B Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 130.29B 1.23B Sep/2026
Stryker USD 47.25B 683M Sep/2026
Tandem Diabetes Care USD 1.16B 5.29M Sep/2026
Teva Pharmaceutical Industries USD 40.04B 185M Sep/2026
Vertex Pharmaceuticals USD 32.74B 5.31B Sep/2026
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026
Zoetis USD 15.09B 11M Sep/2026